In pursuit of a selective hepatocellular carcinoma therapeutic agent: Novel thalidomide derivatives with antiproliferative, antimigratory and STAT3 inhibitory properties

Michael J. Nutt, Yeung Sing Yee, Amanda Buyan, Neil Andrewartha, Ben Corry, George C.T. Yeoh^*, Scott G. Stewart^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review